MoneyLife - Market call with Noland Langford
Investment columnist, Chuck Jaffe welcomes back Noland Langford to talk through Left Brain's hot sectors for capital appreciation and how the firm continues to dig deeper than other firms in their stock and bond selection.
ValueWalk's Hidden Value Stocks - Noland Langford of Left Brain Capital
An in-depth profile on Left Brain Capital Management, chronicling its outperformance in 2016, investment process and some favorite stocks for 2018.
June 6, 2018
ValueWalk - The Under The Radar Hedge Fund Crushing The Market With its Tech Picks
Left Brain Capital Management's stellar lifetime performance - 256.6% since inception - and the investment thinking behind it is the subject of this feature.
Voyage Chicago - Meet Noland Langford of Left Brain Capital Management
“Working at a Wall Street brokerage has its limitations. I wanted more freedom to serve my clients in a way that put their interest above the firm’s.”
Black Enterprise - Invest in These 5 Stocks Now, Says Top African-American Investment Manager
Noland Langford provides business leaders and entrepreneurs with ideas on where to invest over the next few years.
MoneyLife - Market Call with Noland Langford
Noland Langford rejoins investment columnist Chuck Jaffe to discuss areas where capital appreciation opportunities look strong in 2018.
August 8, 2017
CNBC - Left Brain CEO: Valeant Earnings A ‘Turnaround Story’
Noland Langford shares Left Brain’s analysis on why Valeant bonds continue to look like a viable option for investors.
August 8, 2017
Barron's - Valeant Bonds Rise on Early Debt Repayment
Noland Langford discusses why Left Brain sees continued upside in Valeant bonds because of their spreads versus U.S. Treasuries.
July 11, 2017
CityWire Americas - Chicago hedge fund sets up Miami office for LatAm push
Citywire Americas highlights Left Brain’s expansion and its strategic focus on the Caribbean.
April 26, 2017
Hedge Fund Alert - Left Brain Leverages Early Returns
A profile of Left Brain’s stellar performance in 2016 and growth plans for 2017.
March 23, 2017
Barron's - A Safer Way to Invest in Valeant. Really.
Noland Langford details how Left Brain is betting on select healthcare companies by buying the bonds, not the stocks.
January 25, 2017
HFM Week- Investors Need to Stop Focusing Solely on Larger Managers
Noland Langford: “Do the due diligence and protect yourselves from riskier investments, but stop turning allocation into an asset-sized beauty pageant.” (Subscription required)
December 30, 2016
Barron's - Scientific Games: Stock is Expensive, But Bonds Yield 11%
Noland Langford talks about one of Left Brain’s latest capital appreciation finds: “[We]… started buying bonds when they were in the $60-$65 range…they have climbed to $83.5.”
December 7, 2016
TheStreet - American Airlines, Health Equity Likely to Keep Rallying Through 2017
Noland Langford offers insight on why some of Left Brain’s favorite stocks could grow in value over the next few years.
December 6, 2016
TheStreet - Five Below, Freeport McMorAn Will Fare Well in 2017
Noland Langford: “We’ve still got a long way to go…and I think the shares are just getting going.”
November 11, 2016
ThinkAdvisor - The Alternatives to Chasing Yield
Noland Langford pens a piece on how the relentless chase for yield can backfire and why a fresh approach to asset allocation is in order.
November 2, 2016
Opalesque - For This Long-Biased Hedge Fund Manager, Flexibility Is Key
A profile of Noland Langford and the Left Brain Capital Appreciation fund, taking a closer look at the fund’s unique approach to asset selection. (Subscription required)
September 30, 2016
Barron's - 4 Energy Bonds that Look Better than the Stocks
Noland Langford: “[With these bonds] you don’t have to take a ton of risk and you can get a double-digit return.”
September 1, 2016
InvestmentNews - Are Junk Bonds Becoming The New Equities?
Noland Langford shares Left Brain’s view on why select high-yield bonds can provide equity-like growth, even as interest rates rise.